Description
Product Description
Larazotide Acetate is a synthetic peptide compound provided in lyophilized powder form and intended strictly for research and laboratory use only. In experimental studies, Larazotide Acetate is primarily investigated for its effects on intestinal epithelial tight junction regulation and paracellular permeability modulation.
Within gastrointestinal and immunology-related research, Larazotide Acetate is frequently used as a tool compound to explore epithelial barrier integrity, inflammatory signaling interactions, and gut permeability–associated mechanisms. Its defined peptide structure and reproducible physicochemical properties make it suitable for controlled in vitro and in vivo experimental models.
Product Specifications
| Item | Description |
|---|---|
| Product Name | Larazotide Acetate |
| Synonyms | AT-1001 Acetate, Larazotide |
| CAS Number | Not officially assigned |
| Molecular Formula | C30H49N9O7·C2H4O2 |
| Molecular Weight | ~651.8 g/mol (acetate salt) |
| Amino Acid Sequence | Gly-Gly-Val-Leu-Val-Gln-Pro-Gly |
| Peptide Type | Synthetic linear peptide |
| Form | Lyophilized powder |
| Purity | ≥98% (HPLC) |
| Strength Options | 1 mg / 5 mg / 10 mg |
| Appearance | White to off-white powder |
| Identity Verification | HPLC, Mass Spectrometry |
| Solubility | Soluble in water |
| Packaging | Sterile, sealed research vials |
| Storage Condition | −20 °C, dry and light-protected |
| Intended Use | Research use only (RUO) |
Key Features
Supplied as high-purity lyophilized powder
Suitable for intestinal barrier and epithelial research
Consistent batch quality for reproducible experiments
Stable peptide form for laboratory storage
Applicable to in vitro and in vivo research models
Applications
Larazotide Acetate is commonly used in the following research areas:
Intestinal epithelial barrier function studies
Tight junction signaling and regulation research
Gastrointestinal inflammation–related models
Gut permeability and paracellular transport investigations
Peptide-based modulation of epithelial integrity research
For mechanistic analysis and pathway-level discussion, refer to the corresponding Larazotide Acetate 03 template research article.
Usage & Reconstitution Guidelines
Larazotide Acetate should be reconstituted under sterile laboratory conditions. The lyophilized powder is typically dissolved in sterile water or appropriate aqueous buffers to prepare stock solutions for experimental use.
Aliquoting after reconstitution is recommended to avoid repeated freeze–thaw cycles. Experimental concentrations and exposure durations should be optimized according to specific research objectives and model systems.
Storage & Stability
Store unopened vials at −8 °C
Protect from moisture and light
Avoid repeated freeze–thaw cycles
Properly stored aliquots remain stable for extended research periods
Shipping Guarantee
Larazotide Acetate lyophilized powder is packaged according to standardized laboratory material handling procedures.
Moisture- and light-protected packaging
Secure outer containers to prevent physical damage
Batch-level labeling for traceability
Handling protocols designed to preserve peptide stability
Payment Support
To support laboratories and research institutions, multiple payment options are available:
Wire Transfer (T/T)
Business-to-business payment methods
Region-specific payment solutions upon request
Documentation Available
The following documentation may be provided upon request:
Certificate of Analysis (COA)
HPLC purity report
Mass spectrometry data
Batch and lot information
Disclaimer
This product is intended for research and laboratory use only.
Not for human or veterinary use.
All handling and experimental applications must comply with applicable laws, institutional policies, and laboratory safety regulations.


Reviews
There are no reviews yet.